FDA Inspection 1195625 — CKD Bio Corporation
The FDA completed an inspection of CKD Bio Corporation on November 18, 2022 in Ansan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 18, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ansan (Korea (the Republic of))